Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.



<ul>
<li>BTIG raised the price target for Oncology Institute Inc (NASDAQ:TOI) from $7 to $8. Piper Sandler analyst Clarke Jeffries maintained a Neutral rating. Oncology Institute shares closed at $4.87 on Friday. See how other analysts view this stock.</li>



<li>JP Morgan increased Victorias Secret &amp; Co. (NYSE:VSXY) price target from $77 to $88. JP Morgan analyst Matthew Boss maintained an Overweight rating. Victorias Secret shares closed at $74.58 on Friday. See how other analysts view this stock.</li>



<li>DA Davidson cut price target for Guidewire Software, Inc. (NYSE:GWRE) from $246 to $222. DA Davidson analyst Peter Heckmann maintained a Buy rating. Guidewire Software shares closed at $136.08 on Friday. See how other analysts view this stock.</li>



<li>Chardan Capital raised the price target for CleanSpark, Inc. (NYSE:CLSK) from $16 to $19. Chardan Capital analyst James McIlree maintained a Buy rating. CleanSpark shares closed at $15.59 on Friday. See how other analysts view this stock.</li>



<li>Rosenblatt raised Navan, Inc. (NASDAQ:NAVN) price target from $20 to $24. Rosenblatt analyst Blair Abernethy maintained a Buy rating. Navan shares closed at $21.20 on Friday. See how other analysts view this stock.</li>



<li>Needham raised Sportradar Group AG (NASDAQ:SRAD) price target from $19 to $23. Needham analyst Bernie McTernan maintained a Buy rating. Sportradar shares closed at $13.90 on Friday. See how other analysts view this stock.</li>



<li>Ascendiant Capital cut Plus Therapeutics, Inc. (NASDAQ:PSTV) price target from $65 to $57. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Plus Therapeutics shares closed at $5.41 on Friday. See how other analysts view this stock.</li>



<li>Chardan Capital cut the price target for Hyperion DeFi, Inc. (NASDAQ:HYPD) from $8.25 to $7.3. Chardan Capital analyst James McIlree maintained a Buy rating. Hyperion DeFi shares closed at $3.50 on Friday. See how other analysts view this stock.</li>



<li>JP Morgan lowered Insmed Incorporated (NASDAQ:INSM) price target from $180 to $179. JP Morgan analyst Jessica Fye maintained an Overweight rating. Insmed shares closed at $94.22 on Friday. See how other analysts view this stock.</li>



<li>Ascendiant Capital cut Cingulate Inc. (NASDAQ:CING) price target from $55 to $52. Ascendiant Capital analyst Edward Woo maintained a Buy rating. Cingulate shares closed at $4.4950 on Friday. See how other analysts view this stock.</li>
</ul>



Considering buying INSM stock? Here’s what analysts think:



<figure class="wp-block-image size-large is-resized"></figure>



Photo via Shutterstock

NAVN

CLSK

Wall Street analysts updated price targets for several stocks. BTIG raised Oncology Institute's target to $8, while Piper Sandler kept a Neutral rating. JP Morgan increased Victoria's Secret's target to $88 and lowered Insmed's to $179. DA Davidson cut Guidewire Software's target to $222. Chardan Capital raised CleanSpark's target to $19 but cut Hyperion DeFi's to $7.30. Rosenblatt raised Navan's target to $24, Needham raised Sportradar's to $23, and Ascendiant cut Plus Therapeutics' and Cingulate's targets.

benzinga_article

Navan

Oncology Institute

CleanSpark

Cingulate

Plus Therapeutics

Hyperion DeFi

Guidewire Software

Victorias Secret

Sportradar Group AG

Insmed

Tradr 2X Long CLSK Daily ETF

Oncology Institute - CW22

CLEANSPARK INC C/WTS 29/12/2028 (TO PUR COM)

CINGULATE INC C/WTS 10/12/2026 (TO PUR COM)

Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Monday